Interaction Between Statins and Rituximab in Non-Hodgkin's Lymphoma

被引：9
|
作者：
Rabinowitz, Ian [1 ]
机构：
[1] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 33期
关键词：
D O I：
10.1200/JCO.2008.19.2849
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5486 / 5486
页数：1
相关论文
共 50 条
  • [11] Progress in rituximab therapy for non-Hodgkin's lymphoma - Introduction
    Linch, D
    SEMINARS IN ONCOLOGY, 2002, 29 (02) : 1 - 1
  • [12] Lenalidomide and rituximab for untreated indolent non-Hodgkin's lymphoma
    Fowler, N. H.
    McLaughlin, P.
    Kwak, L.
    Hagemeister, F.
    Fanale, M.
    Fayad, L.
    Pro, B.
    Samaniego, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [13] Rituximab shows additional promise in non-Hodgkin's lymphoma
    不详
    ONCOLOGY-NEW YORK, 1999, 13 (08): : 1068 - +
  • [14] The preclinical discovery of rituximab for the treatment of non-Hodgkin's lymphoma
    Smolewski, Piotr
    Robak, Tadeusz
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (07) : 791 - 808
  • [15] Rituximab for Non-Hodgkin's Lymphoma: A Story of Rapid Success in Translation
    Harrison, Andrew M.
    Thalji, Nassir M.
    Greenberg, Alexandra J.
    Tapia, Carmen J.
    Windebank, Anthony J.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2014, 7 (01): : 82 - 86
  • [16] B cell non-Hodgkin's lymphoma: rituximab safety experience
    Mohrbacher, A
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 3) : S19 - S25
  • [17] B cell non-Hodgkin's lymphoma: rituximab safety experience
    Ann Mohrbacher
    Arthritis Research & Therapy, 7
  • [18] Rituximab for the Treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia
    Fredrick Hagemeister
    Drugs, 2010, 70 : 261 - 272
  • [19] CD47 Blockade and Rituximab in Non-Hodgkin's Lymphoma
    Valerius, Thomas
    Roesner, Thies
    Leusen, Jeanette H. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (05): : 496 - 497
  • [20] Cost Effectiveness of Rituximab for Non-Hodgkin's Lymphoma A Systematic Review
    Auweiler, Philipp W. P.
    Mueller, Dirk
    Stock, Stephanie
    Gerber, Andreas
    PHARMACOECONOMICS, 2012, 30 (07) : 537 - 549
12345